Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,471.00    14.60 (1.00%)
Bid:
1,471.60
Ask:
1,471.80
Spread: 0.20 (0.014%)
Market Cap: £252.25b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Notice of redemption

24 Sep 2025 10:00

RNS Number : 6327A
HSBC Holdings PLC
24 September 2025
 

 

24 September 2025

 

 

HSBC HOLDINGS PLC

NOTICE OF REDEMPTION AND CANCELLATION OF LISTING

 

To the holders of:

 

(i) GBP1,000,000,000 2.256 per cent. Resettable Notes due November 2026

ISIN Code: XS1716248197

(the 'Series 33 Notes')

and

(ii) EUR1,000,000,000 0.309 per cent. Fixed to Floating Rate Notes due 2026

ISIN Code: XS2251736646

(the 'Series 40 Notes' and together with the Series 33 Notes, the 'Notes')

 

 

Notice is hereby irrevocably given to:

 

(i) the holders of the Series 33 Notes (the 'Series 33 Noteholders') that, pursuant to Condition 6(c) (Redemption at the Option of the Issuer) of the terms and conditions of the Series 33 Notes and paragraph 16 (Issuer's optional redemption (Call): Condition 6(c)) of the final terms dated 9 November 2017, as amended and restated on 29 October 2021, relating to the Series 33 Notes (the 'Series 33 Final Terms'), on 13 November 2025 (the 'Series 33 Redemption Date') HSBC Holdings plc will exercise its option to redeem all of the outstanding Series 33 Notes at GBP1,000 per Calculation Amount (as defined in the Series 33 Final Terms), together with accrued but unpaid interest from (and including) 13 November 2024 to (but excluding) the Series 33 Redemption Date; and

 

(ii) the holders of the Series 40 Notes (the 'Series 40 Noteholders') that, pursuant to Condition 6(c) (Redemption at the Option of the Issuer) of the terms and conditions of the Series 40 Notes and paragraph 16 (Issuer's optional redemption (Call): Condition 6(c)) of the final terms contained in the section entitled 'Terms and Conditions of the 2026 Notes - Final Terms' of the drawdown prospectus dated 11 November 2020 relating to the Series 40 Notes (the 'Series 40 Final Terms'), on 13 November 2025 (the 'Series 40 Redemption Date') HSBC Holdings plc will exercise its option to redeem all of the outstanding Series 40 Notes at EUR1,000 per Calculation Amount (as defined in the Series 40 Final Terms), together with accrued but unpaid interest from (and including) 13 November 2024 to (but excluding) the Series 40 Redemption Date.

 

Noteholders should look to the relevant clearing systems through which their Notes are held for repayment.

 

The listing of the Notes on the Official List of the Financial Conduct Authority and the admission of the Notes to trading on the Main Market of the London Stock Exchange plc will be cancelled on, or shortly after, 14 November 2025.

 

Investor enquiries to:

Greg Case +44 (0) 20 7992 3825 investorrelations@hsbc.com

 

Media enquiries to:

Press Office +44 (0) 20 7991 8096 pressoffice@hsbc.com

 

 

Note to editors:

 

HSBC Holdings plc

 

HSBC Holdings plc, the parent company of HSBC, is headquartered in London. HSBC serves customers worldwide from offices in 57 countries and territories. With assets of US$3,214bn at 30 June 2025, HSBC is one of the world's largest banking and financial services organisations.

 

The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the 'Securities Act'), or any state securities laws and, unless so registered, may not be offered or sold within the United States or to, or for the account or the benefit of, US persons, as defined in Regulation S under the Securities Act, except pursuant to an exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable state securities laws.

 

ends/all

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGZLRDVGKZG
Date   Source Headline
10th Jul 20269:30 amRNSOverseas Regulatory Announcement - Grant of Awards
2nd Jul 20263:45 pmRNSNotice of redemption
30th Jun 20264:00 pmRNSNotification of Transactions by PDMRs
30th Jun 20263:00 pmRNSTotal Voting Rights
30th Jun 20269:18 amRNSHolding(s) in Company
22nd Jun 20263:13 pmRNSHolding(s) in Company
18th Jun 20261:04 pmRNSHolding(s) in Company
17th Jun 202610:08 amRNSPre Stabilisation Notice
15th Jun 20264:12 pmRNSHolding(s) in Company
15th Jun 20261:00 pmRNSFirst Interim Dividend for 2026 - Exchange Rate
11th Jun 20265:10 pmRNSNotice of redemption
2nd Jun 20262:41 pmRNSHolding(s) in Company
29th May 20264:01 pmRNSTotal Voting Rights
29th May 20264:00 pmRNSNotification of issuance under block listing
27th May 20264:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSIssuance of senior unsecured notes
21st May 20267:00 amRNSHSBC investor and analyst Asia seminar
20th May 20267:00 amRNSHSBC investor and analyst Asia seminar
18th May 20264:20 pmRNSIssuance of perpetual subordinated CC securities
15th May 202611:00 amRNSNotice of redemption and cancellation of listing
12th May 20264:40 pmRNSIssuance of senior unsecured notes (USD)
12th May 20264:05 pmRNSIssuance of senior unsecured notes
12th May 20267:00 amRNSIssuance of perpetual subordinated CCS
8th May 20262:15 pmRNSResult of AGM
8th May 202610:03 amRNSAGM Statements
7th May 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
6th May 202610:00 amRNSBoard and Committee Composition
5th May 202612:30 pmRNSPublication of base prospectus supplement
5th May 20267:00 amRNSEarnings Release 1Q26 Zoom Meeting
5th May 20267:00 amRNSEarnings Release 1Q26
1st May 20264:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:01 pmRNSTotal Voting Rights
30th Apr 20263:00 pmRNSNotification of issuance under block listing
28th Apr 20269:51 amRNSHolding(s) in Company
23rd Apr 202610:00 amRNSNotice of redemption & cancellation of listing
22nd Apr 202610:00 amRNSOverseas Regulatory Announcement - Board Meeting
20th Apr 202612:45 pmRNSFourth Interim Dividend for 2025 - Exchange Rate
17th Apr 20267:00 amRNSAmended and Restated Notice of Redemption
16th Apr 20262:30 pmRNSNotice of redemption
16th Apr 20269:02 amRNSHolding(s) in Company
14th Apr 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
30th Mar 20265:01 pmRNSTotal Voting Rights
30th Mar 20265:00 pmRNSNotification of issuance under block listing
30th Mar 20264:40 pmRNSPublication of base prospectus
27th Mar 20261:30 pmRNSIssuance of senior unsecured notes
27th Mar 20269:00 amRNS2026 AGM - Documents available at NSM
26th Mar 20264:00 pmRNSDirector/PDMR Shareholding
25th Mar 20269:30 amRNSHong Kong Waiver-Contingent Convertible Securities
24th Mar 20264:30 pmRNSDirector/PDMR Shareholding
24th Mar 20263:50 pmRNSIssuance of contingent convertible securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.